These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


574 related items for PubMed ID: 11955535

  • 1. Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trial.
    Petra Study Team.
    Lancet; 2002 Apr 06; 359(9313):1178-86. PubMed ID: 11955535
    [Abstract] [Full Text] [Related]

  • 2. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N, van der Merwe L, Brocklehurst P, Sint TT.
    Cochrane Database Syst Rev; 2011 Jul 06; (7):CD003510. PubMed ID: 21735394
    [Abstract] [Full Text] [Related]

  • 3. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Volmink J, Siegfried NL, van der Merwe L, Brocklehurst P.
    Cochrane Database Syst Rev; 2007 Jan 24; (1):CD003510. PubMed ID: 17253490
    [Abstract] [Full Text] [Related]

  • 4. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial.
    Jackson JB, Musoke P, Fleming T, Guay LA, Bagenda D, Allen M, Nakabiito C, Sherman J, Bakaki P, Owor M, Ducar C, Deseyve M, Mwatha A, Emel L, Duefield C, Mirochnick M, Fowler MG, Mofenson L, Miotti P, Gigliotti M, Bray D, Mmiro F.
    Lancet; 2003 Sep 13; 362(9387):859-68. PubMed ID: 13678973
    [Abstract] [Full Text] [Related]

  • 5. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
    Kesho Bora Study Group, de Vincenzi I.
    Lancet Infect Dis; 2011 Mar 13; 11(3):171-80. PubMed ID: 21237718
    [Abstract] [Full Text] [Related]

  • 6. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial.
    Guay LA, Musoke P, Fleming T, Bagenda D, Allen M, Nakabiito C, Sherman J, Bakaki P, Ducar C, Deseyve M, Emel L, Mirochnick M, Fowler MG, Mofenson L, Miotti P, Dransfield K, Bray D, Mmiro F, Jackson JB.
    Lancet; 1999 Sep 04; 354(9181):795-802. PubMed ID: 10485720
    [Abstract] [Full Text] [Related]

  • 7. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Brocklehurst P, Volmink J.
    Cochrane Database Syst Rev; 2002 Sep 04; (2):CD003510. PubMed ID: 12076484
    [Abstract] [Full Text] [Related]

  • 8. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Brocklehurst P, Volmink J.
    Cochrane Database Syst Rev; 2002 Sep 04; (1):CD003510. PubMed ID: 11869666
    [Abstract] [Full Text] [Related]

  • 9. Promising findings from the PETRA study of perinatal transmission.
    Hanna L.
    BETA; 1999 Apr 04; 12(2):19. PubMed ID: 11366687
    [Abstract] [Full Text] [Related]

  • 10. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study.
    Thior I, Lockman S, Smeaton LM, Shapiro RL, Wester C, Heymann SJ, Gilbert PB, Stevens L, Peter T, Kim S, van Widenfelt E, Moffat C, Ndase P, Arimi P, Kebaabetswe P, Mazonde P, Makhema J, McIntosh K, Novitsky V, Lee TH, Marlink R, Lagakos S, Essex M, Mashi Study Team.
    JAMA; 2006 Aug 16; 296(7):794-805. PubMed ID: 16905785
    [Abstract] [Full Text] [Related]

  • 11. A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.
    Moodley D, Moodley J, Coovadia H, Gray G, McIntyre J, Hofmyer J, Nikodem C, Hall D, Gigliotti M, Robinson P, Boshoff L, Sullivan JL, South African Intrapartum Nevirapine Trial (SAINT) Investigators.
    J Infect Dis; 2003 Mar 01; 187(5):725-35. PubMed ID: 12599045
    [Abstract] [Full Text] [Related]

  • 12. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS, Dokubo EK, Sint TT.
    Cochrane Database Syst Rev; 2010 Mar 17; (3):CD008440. PubMed ID: 20238370
    [Abstract] [Full Text] [Related]

  • 13. Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trial.
    Wiktor SZ, Ekpini E, Karon JM, Nkengasong J, Maurice C, Severin ST, Roels TH, Kouassi MK, Lackritz EM, Coulibaly IM, Greenberg AE.
    Lancet; 1999 Mar 06; 353(9155):781-5. PubMed ID: 10459958
    [Abstract] [Full Text] [Related]

  • 14. Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission.
    Dabis F, Bequet L, Ekouevi DK, Viho I, Rouet F, Horo A, Sakarovitch C, Becquet R, Fassinou P, Dequae-Merchadou L, Welffens-Ekra C, Rouzioux C, Leroy V, ANRS 1201/1202 DITRAME PLUS Study Group.
    AIDS; 2005 Feb 18; 19(3):309-18. PubMed ID: 15718842
    [Abstract] [Full Text] [Related]

  • 15. Extended pre-exposure prophylaxis with lopinavir-ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trial.
    Nagot N, Kankasa C, Tumwine JK, Meda N, Hofmeyr GJ, Vallo R, Mwiya M, Kwagala M, Traore H, Sunday A, Singata M, Siuluta C, Some E, Rutagwera D, Neboua D, Ndeezi G, Jackson D, Maréchal V, Neveu D, Engebretsen IMS, Lombard C, Blanche S, Sommerfelt H, Rekacewicz C, Tylleskär T, Van de Perre P, ANRS 12174 Trial Group.
    Lancet; 2016 Feb 06; 387(10018):566-573. PubMed ID: 26603917
    [Abstract] [Full Text] [Related]

  • 16. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
    Tonwe-Gold B, Ekouevi DK, Viho I, Amani-Bosse C, Toure S, Coffie PA, Rouet F, Becquet R, Leroy V, El-Sadr WM, Abrams EJ, Dabis F.
    PLoS Med; 2007 Aug 06; 4(8):e257. PubMed ID: 17713983
    [Abstract] [Full Text] [Related]

  • 17. Systematic review of the efficacy of antiretroviral therapies for reducing the risk of mother-to-child transmission of HIV infection.
    Suksomboon N, Poolsup N, Ket-Aim S.
    J Clin Pharm Ther; 2007 Jun 06; 32(3):293-311. PubMed ID: 17489882
    [Abstract] [Full Text] [Related]

  • 18. Elective cesarean delivery plus short-course lamivudine and zidovudine for the prevention of mother-to-child transmission of human immunodeficiency virus type 1.
    Panburana P, Sirinavin S, Phuapradit W, Vibhagool A, Chantratita W.
    Am J Obstet Gynecol; 2004 Mar 06; 190(3):803-8. PubMed ID: 15042018
    [Abstract] [Full Text] [Related]

  • 19. 6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. DITRAME Study Group. DIminution de la Transmission Mère-Enfant.
    Dabis F, Msellati P, Meda N, Welffens-Ekra C, You B, Manigart O, Leroy V, Simonon A, Cartoux M, Combe P, Ouangré A, Ramon R, Ky-Zerbo O, Montcho C, Salamon R, Rouzioux C, Van de Perre P, Mandelbrot L.
    Lancet; 1999 Mar 06; 353(9155):786-92. PubMed ID: 10459959
    [Abstract] [Full Text] [Related]

  • 20. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group.
    Shaffer N, Chuachoowong R, Mock PA, Bhadrakom C, Siriwasin W, Young NL, Chotpitayasunondh T, Chearskul S, Roongpisuthipong A, Chinayon P, Karon J, Mastro TD, Simonds RJ.
    Lancet; 1999 Mar 06; 353(9155):773-80. PubMed ID: 10459957
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 29.